Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Osteoporosis
Interventions: DRUG: letrozole|DRUG: zoledronic acid
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)